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Abstract
Expression of IL-7 receptor a (CD127) is associated with naive and memory (i.e. non-effector) CD8
1
T cell phenotypes. Effector CD8
1 T cells are predominantly CD127
2 and most die by apoptosis.
Therefore, CD127 appears to be a marker for CD8
1 T cell differentiation, yet its role in CD8
1 T cell
survival and memory development is unclear. To address this, we investigated the cell death and cell
division of isolated CD8
1CD127
1 and CD8
1CD127
2 T cells in response to common IL-2 receptor
g chain (gC) cytokines other than IL-7. We show here that (i) memory cells (CD127
1CD45RA
2) divide
frequently in response to either IL-2, -4 or -15; (ii) IL-2 and -15 enhance cell division in effector–
memory-like cells (CD127
2CD45RA
1) while IL-4 enhances the cell division of effector cells
(CD127
2CD45RA
2); (iii) CD8
1CD127
1 T cells are more sensitive to the anti-apoptotic effects of IL-2 or
IL-15 than CD8
1CD127
2 T cells and (iv) CD8
1CD127
1 T cell produce more Bcl-2 in response to IL-2 or
IL-15 compared with CD8
1CD127
2 T cells. Therefore, CD8
1CD127
1 and CD8
1CD127
2 T cells differ in
their responsiveness to cell division and anti-apoptotic signals from IL-2, -4 and -15. This suggests
a role for gC cytokines in the pathogenesis of diseases in which CD127 expression is altered on CD8
1
T cells such as in progressive viral infections and cancer.
Introduction
Homeostatic maintenance of CD8
+ Tcells requires the delivery
and balance of cell proliferation, survival and apoptosis-
inducing signals. These signals are mainly derived from cyto-
kines whose receptor complexes share a common IL-2
receptor c chain (cC) (IL-2, 4, 7, 9, 15 and 21) and have simi-
lar downstream signaling pathways (1). It is now well estab-
lished that IL-7 is critical for T cell development and that along
with IL-2, -4, -7 and -15 maintains naive and memory T cells
(2–6). There is some redundancy among the roles of IL-2 and
IL-15 in stimulating T cell proliferation in vitro,y e tin vivo,t h e s e
cytokines are associated with the induction of cell death and
survival of T cell clones, respectively (7). Speciﬁcally, high con-
centrations of IL-2 are associated with increased activation-
induced cell death of CD8
+ T cells, while IL-4 inhibits the latter
(8). IL-15 has been well described to have an important role
in the survival of naive and memory CD8
+ T cells (9–11). It
is thought that the extent of cell death incurred following the
contraction phase of a CD8
+ T cell response is related in
part to events determining the extent of cell division and this
may inﬂuence memory T cell development (12).
A typical CD8
+ T cell response includes the activation of
naive cells (Tnaive), clonal expansion of effector cells follow-
ed by a contraction of effector cells and establishment of
memory cells which include central memory (TCM), effector–
memory (TEM) and CD45RA
+ effector–memory (TEMRA) T cells
(13–16). The expression of IL-7 receptor a (CD127) is found
primarily on naive and memory T cells (17, 18) while CD127
expression is down-regulated in most effector cells (3). The
proportion of CD8
+ T cell subsets expressing CD127 in
healthy individuals is as follows: naive > TEM and TCM >
effector. Functionally, it has been shown that CD8
+CD127

T cells produced IFN-c and tumor necrosis factor-a but not
IL-2 and were more spontaneously apoptotic and more prone
to activation-induced apoptosis and proliferated somewhat
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+ T cells (19, 20). Therefore, CD127 expres-
sion may be a determinant of CD8
+ T cell survival (17) and
certain cytokines may have a role in determining CD8
+ T cell
fate and function.
The expression of CD127 on CD8
+ T cells is of particular
relevance to anti-viral responses as a down-regulation of
CD127 expression has been observed in infections with la-
tent viruses such as epstein-barr virus (EBV) and cytomega-
lovirus (CMV) as well as in chronic viral infections such as
HIV and HCV (21–24). In chronic viral infections, this has
been correlated with CD8
+ T cell exhaustion in the context
of persistent exposure to antigen. We and others have dem-
onstrated that signiﬁcantly fewer CD8
+ T cells express
CD127 in HIV-infected patients with uncontrolled plasma vi-
remia compared with healthy individuals (22, 23, 25, 26). In
a recent report, HIV-infected patients had an increased ex-
pansion of effector-like CD8
+ T cells lacking CD127 which
correlated with markers of disease progression such as
plasma viremia and CD4
+ T cell depletion, supporting
reports in inbred laboratory rodents that CD127 is an impor-
tant marker of functionally distinct CD8
+ T cell subsets (19).
The impact of altered CD127 expression and immune sys-
tem dysfunction in chronic viral infections is not known nor
is how this explains the maintenance of CD8
+ T cell homeo-
stasis in healthy individuals.
Differences in the cytokine responsiveness of naive, effec-
tor and memory CD8
+ T cell subsets have been described
elsewhere, although not in the context of CD127 expression
(3, 10, 13, 27, 28). Evidence suggests that the expression
of CD127 is associated with different cell phenotypes and
differentiation pathways of CD8
+ T cell responses during
which signiﬁcant cell proliferation and cell death occur. Fur-
thermore, the proportion of cells expressing CD127 has
been correlated with disease status (22, 23, 25, 26). We hy-
pothesized that the expression of CD127 is associated with
CD8
+ T cell survival. Therefore, we investigated the survival
features of isolated CD8
+CD127
+ and CD8
+CD127
 T cells
and the inﬂuence of cC cytokines.
Materials and methods
Isolation of CD8
+CD127
+ and CD8
+CD127
 T cells from
human peripheral blood
All research conducted using blood from human subjects
were approved by the Ottawa Hospital Research Ethics
Board. Blood was collected from healthy volunteers into hep-
arin-containing tubes and PBMC were isolated by Ficoll-
Hypaque density gradient centrifugation. Brieﬂy, CD8
+
Tcells were isolated using the human CD8
+ T cell isolation kit
II following the manufacturer’s instructions (Miltenyi Biotec,
Auburn, CA, USA) along with the autoMACS cell sorter’s ‘de-
plete’ protocol to remove non-CD8
+ T cells (Miltenyi Biotec).
Cells were then cultured (1 3 10
6 cells ml
1) overnight
in complete RPMI medium [supplemented with 20% FCS
(Cansera, Etobicoke, Ontario, Canada), 100 IU ml
1 each of
penicillin and streptomycin (Sigma–Aldrich, Oakville,
Ontario, Canada)]. The CD127
+ and CD127
 cells were sep-
arated by labeling CD8
+ T cells with PE-conjugated mouse
anti-human CD127 mAbs (65 ll per 1 3 10
7 cells, Beckman
Coulter, Mississauga, Ontario, Canada) in PBS + 0.5% bo-
vine serum (Sigma–Aldrich) + 0.05 mM EDTA (binding
buffer, 80 ll per 1 3 10
7 cells) and incubated for 15 min at
4 C. Cells were washed and labeled with mouse anti-PE
mAbs conjugated to paramagnetic beads (40 ll per 1 3
10
7 cells, Miltenyi Biotec) in binding buffer (80 ll per 1 3
10
7 cells) for 15 min at 4 C. Cells were washed, re-
suspended in binding buffer and separated using the auto-
MACS cell sorter’s ‘possels’ protocol to separate the
antibody-labeled CD127
+ T cells from the CD127
 T cells.
The CD8
+ T cell isolation typically yielded a >95% pure pop-
ulation (data not shown), with minimal numbers of CD4
+
T cells and no contaminating monocytes/macrophages, den-
dritic cells, B cells or NK cells. The separation of CD127
subsets typically enriched a CD127
+ population (>95%
CD127
+) and a CD127
 population (<12% CD127
+), compa-
rable to similar methods used to enrich other CD8
+ T cell
subsets (29). Expression of cC cytokine receptors was
assessed using FITC-conjugated anti-IL-2Ra (Beckman
Coulter) and anti-IL-2Rb (R&D Systems), PE-conjugated
IL-2Rc (BD Pharmingen, San Diego, CA, USA), biotinylated
IL-4Ra and anti-IL-15Ra (R&D Systems) and streptavidin
R-PE conjugate (Sigma-Aldrich).
CFSE labeling and culture conditions for cell cycling
experiments
Following isolation, cells were labeled with CFSE (CellTrace
TM
CFSE Cell Proliferation Kit) using a method modiﬁed from
the manufacturer’s speciﬁcations (Invitrogen Canada Inc.,
Burlington, Ontario, Canada). A stock solution (5 mM) of
CFSE was prepared in dimethyl sulfoxide followed by the
preparation of a working solution (8 lM) of Carboxyﬂuores-
cein succinimdyl ester (CFSE) in PBS + 0.1% BSA. Cells
were re-suspended in CFSE working solution (1 3 10
7 cells
ml
1) and incubated at 37 C, in the dark for 10 min. Cell
were incubated with 15 volumes of cold complete RPMI on
ice, in the dark for 5 min and then washed and re-
suspended in complete RPMI (1 3 10
6 cells ml
1). Cells
were cultured with medium only, PHA (2.5 lgm l
1, Sigma–
Aldrich), IL-2 (1, 10, 100 units ml
1), IL-4 or IL-15 (1, 10,
100 ng ml
1) (R&D Biosystems, Minneapolis, MN, USA). The
concentration of PHA used was the lowest tested concentra-
tion (i.e. submaximal dose) that induced at least two rounds
of cell division among activated cells. Cells were cultured
for 4 days and then cell division was assessed by ﬂow
cytometry.
Quantitative ﬂow cytometry analysis of cell cycling
Following 4 days of cell culture, CFSE-labeled cells were la-
beled with mouse anti-human CD45RA-ECD and mouse anti-
human CD8-PC5 and analyzed by ﬂow cytometry (Beckman
Coulter ALTRA ﬂow cytometer and the EXPO version 2.0
software package). Color compensation was conducted in
accordance with the ﬂuorescence-minus-one strategy using
single- and double-stained samples. A total of 15 000 events
were collected for each sample ensuring the inclusion of a sufﬁ-
cient number (1000–3000) of stimulated T cells for analysis.
The gating strategy involved the examination of cell division
among stimulated T cells identiﬁed on the basis of increased
forward and side scatter proﬁles, a known feature of dividing
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vided into CD8
+CD45RA
+ or CD8
+CD45RA
 T cell subsets to
identify the following cell phenotypes: CD8
+CD127
+CD45RA
+
(naive), CD8
+CD127
+CD45RA
 (central memory, TCM),
CD8
+CD127
CD45RA
+ (effector/effector–memory, TE/TEM)
and CD8
+CD127
CD45RA
 (RA
+ effector–memory like,
TEMRA). Individual cell divisions of the stimulated T cells were
noted according to previously described methods involving
CFSE analysis of T cell division (31, 32). The proportion of
stimulated T cells that have undergone >3 divisions as deter-
mined by the last detectable division (% CFSE
lo).
Flow cytometry analysis of surface Fas and intracellular
Bcl-2 expression
Isolated CD8
+CD127
+ and CD8
+CD127
 T cells were incu-
bated with medium, IL-2 (100 units ml
1, R&D Systems) or
IL-15 (100 ng ml
1) for 48 h and then incubated with mouse
anti-human CD95 mAb (CH11) (3.3 lgm l
1, Beckman Coulter)
to induce Fas-mediated apoptosis or mouse anti-human
CD3 mAb (HIT3a) (1 lgm l
1, BD Biosciences, Mississauga,
Ontario, Canada) to induce CD3-mediated apoptosis as de-
scribed previously (33). Intracellular Bcl-2 staining was per-
formed using the BD Biosciences FITC-conjugated Bcl-2
antibody reagent set, following the manufacturer’s protocol.
Cells were washed with PBS and re-suspended in ﬁxation
buffer (100 ll per 10
5 cells, eBiosciences, San Diego, CA,
USA) and incubated at room temperature for 20 min. Follow-
ing incubation, cells were washed, re-suspended in permea-
bilization buffer (100 ll per 10
5 cells) with FITC-conjugated
Bcl-2 antibody (2 ll per 10
5 cells, BD Biosciences) and incu-
bated at room temperature for 20 min. Samples were
washed and then re-suspended in ﬂow staining buffer (0.5 ml
per 10
5 cells, eBiosciences). Analysis was performed by ﬂow
cytometry and data are represented as values of mean ﬂuo-
rescence intensity.
The expression of surface Fas on freshly isolated
CD8
+CD127
+ and CD8
+CD127
 T cells was assessed ﬂow
cytometry using mouse-anti-human Fas-FITC mAb (BD
Biosciences).
Analysis of apoptosis
Three ﬂow cytometry-based methods were used to assess
apoptosis: Annexin V–phosphatidylinositol (PI) staining and
analysis of caspase-3 and caspase-8 activity. Isolated
CD8
+CD127
+ and CD8
+CD127
 T cells were pre-incubated
for 48 h with medium, IL-2 (100 units ml
1) or IL-15 (100 ng
ml
1) then incubated with anti-human CD95 or anti-human
CD3 as described above. Isotype controls were used to
conﬁrm Fas- and CD3-speciﬁc apoptosis. The Annexin V–PI
staining was performed using the Annexin V–FITC Apoptosis
Detection Kit I, according to the manufacturer’s instructions
(BD Pharmingen). Apoptotic cells (Annexin–V
+PI
) were dis-
tinguished from dead cells (Annexin–V
+PI
+) and data are
represented as the % of Annexin–V
+PI
 cells/(% Annexin–
V
+PI
 cells + % Annexin–V
PI
 cells), gating on all cells.
Caspases-3 and -8 activity was determined using Carboxy-
ﬂuorescein Caspase Detections Kits following the manufac-
turer’s instructions (Biocarta, San Diego, CA, USA). These
kits detect active caspases in living cells using a carboxy-
ﬂuorescein (FAM)-labeled peptide ﬂuoromethyl ketone
(FMK) caspase inhibitor that irreversibly binds to active cas-
pases (FAM-DEVD-FMK for caspase-3 and FAM-LETD-FMK
for caspase-8). Given the observed individual variation in
the mean ﬂuorescence intensity of when measuring intracel-
lular caspase staining, data were collected and the relative
caspase activity was calculated by dividing % of caspase
positive cells in response to apoptotic stimuli with or without
cytokine pre-treatment by its appropriate control. In all
assays of apoptosis, a sample of cells was incubated with
camptothecin (10 lM) (Sigma–Aldrich) as a positive control.
Cytokine signaling
The phosphorylation of STAT5 (pSTAT5) in CD8
+ T cells was
analyzed by ﬂow cytometry (Alexa Fluor 488 mouse anti-
human STAT5 pY694, BD Biosciences, San Jose, CA, USA)
following 15 min of culture. Phosphorylated Akt and FOXO3a
in cell lysates were assessed by western blot after 2 h of
culture. As a loading control, the expression of beta-actin
was detected using a mouse anti-human mAb (Cell Signal-
ing Technology, Danvers, MA, USA). Cell pellets were col-
lected by centrifugation and lysed by incubating in lysis
buffer (40 ll per 10
7) for 1 h. Lysates were then centrifuged
for 20 min at 14 000 r.p.m., 4 C and supernatants were col-
lected and stored at 20 C. Lysate concentrations were
quantiﬁed using a BCA Protein Assay Kit (Pierce Biotechnol-
ogies, Rockford, IL, USA). A total of 5 lg of protein was re-
solved by SDS–PAGE and blotted onto polyvinylidene
ﬂuoride membrane. Membranes were blocked overnight in
5% skim milk in Tris-buffered saline, probed with a rabbit
anti-human pAktser or anti-humanantibody followed by
a anti-rabbit-IgG HRP antibody (Cell Signaling Technology,
Boston, MA, USA). Proteins were detected by ECL (Pierce
Biotechnologies). Densitometry analysis of protein bands
was performed using AlphaEase Fc Software 6.0 (Alpha
Innotech Corp., San Leandro, CA, USA) and relative
changes in protein expression of treated cells were calcu-
lated compared with unstimulated controls.
Statistical analysis
Statistical analysis was performed using the Student’s t-test
for paired samples (GraphPad Prism 4.0 Software, San
Diego, CA, USA). Following ﬂow cytometry analysis, elec-
tronic sample ﬁles were further analyzed using the FCS
Express 2.0 software (De Novo Software, Thornhill, Ontario,
Canada). Flow cytometry ﬁgures were generated by FCS
Express 2.0 software. Data calculations were performed us-
ing Microsoft Excel and were subsequently plotted using
GraphPad Prism 4.0 software.
Results
Proliferation of CD8
+CD127
+ and CD8
+CD127
 T cells differ
in response to cC cytokines
It has been well described that IL-2, -4 and -15 promote the sur-
vival and proliferation of CD8
+ Tcells (7, 10, 11, 13, 34). There-
fore, we studied the effects of IL-2, IL-4 and IL-15 on cell
division of mitogen-stimulated, CFSE-labeled, CD8
+CD127
+
and CD8
+CD127
 T cells using a ﬂow cytometry strategy
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in the expression of cC cytokine receptors was observed in ei-
ther of these populations (Table 1). Incubation of CD8
+
T cells with cytokine alone did not result in an appreciable
number of cells undergoing multiple cell divisions, i.e. %
CFSE
lo (data not shown). As mentioned in the Methods,
a submaximal concentration of PHA was used to stimulate
T cells in vitro in order to study cytokine effects.
Submaximal concentrations of PHA induced only a modest
degree of proliferation in CD8
+CD127
+ and CD8
+CD127

T cells (Fig. 2A and B). The addition of IL-2, -4 or -15 at all
concentrations tested signiﬁcantly increased the proportion
of CFSE
lo CD8
+CD127
+ T cells compared with cells cultured
with PHA alone (Fig. 2A, P < 0.05). Only IL-15 and IL-2 sig-
niﬁcantly increased the proportion of CFSE
lo CD8
+CD127

T cells compared with PHA alone (Fig. 2B). Therefore, IL-2,
-4 and -15 increased the proportion of CFSE
lo CD8
+CD127
+
T cells while the CD8
+CD127
 T cells only responded signiﬁ-
cantly to IL-2 and IL-15. This suggests that there are differ-
ences in the proliferative capacities of these two cell
populations, and this may be further pronounced in the
study of Tnaive,T CM,T EM and TEMRA subsets.
Cell division of CD8
+CD127
+CD45RA
+T cells (naive).
Incubation with a submaximal concentration of PHA in-
creased the proportion of naive (CD45RA
+) T cells in the
CD127
+ T cell cultures that underwent up to two cell divi-
sions compared with unstimulated controls (P = 0.007,
Fig. 3A). The addition of IL-4 or IL-15 with PHA did not alter
this signiﬁcantly (Fig. 3A). All tested concentrations of IL-2
signiﬁcantly increased cell division and the proportion of
CFSE
lo cells (P = 0.001). These results indicate that IL-2,
but not IL-4 and IL-15, enhances the proliferation of primed
CD8
+CD127
+CD45RA
+ T cells.
Cell division of CD8
+CD127
+CD45RA
 T cells (TCM). The
proportion of CFSE
lo CD8
+CD127
+CD45RA
 T cells signiﬁ-
cantly increased in response to PHA compared with unsti-
mulated controls (Fig. 3B). The addition of IL-2 (1–100 units
ml
1), IL-4 (1–100 ng ml
1) or IL-15 (10–100 ng ml
1) signif-
icantly increased the proportion of CFSE
lo CD127
+CD45RA

cells (P < 0.05). Therefore, IL-2, IL-4 and IL-15 increased
the proportion of CD8
+CD127
+CD45RA
 T cells undergoing
multiple divisions. It is also notable that stimulation with IL-2
or IL-4 tended to result in a greater proportion of CFSE
lo
CD8
+CD127
+CD45RA
 T cells compared with IL-15, al-
though this did not reach statistical signiﬁcance.
Cell division of CD8
+CD127
CD45RA
+ T cells (TEMRA).
Culturing CD8
+CD127
CD45RA
+ T cells with PHA-alone-
induced cells to undergo more than one cell division com-
pared with unstimulated controls. In addition, IL-2, IL-4 or
IL-15 increased the proportion of dividing CD127
CD45RA
+
T cells compared with PHA alone (Fig. 3C). All concentra-
tions of IL-15 (1, 10 and 100 ng ml
1) tested signiﬁcantly in-
creased the proportion of CFSE
lo cells (P = 0.031, 0.036
and 0.052, respectively, compared with PHA alone).
Table 1. Summary of cC cytokine receptor expression in isolated CD8
+CD127
+ and CD8
+CD127
 T cells
a
CD8
+CD127
+ CD8
+CD127

% expression
b MFI
c % expression MFI
IL-2Ra 18.1 6 1.62 15.63 6 2.05 15.16 6 3.41 15.03 6 4.55
IL-2Rb 26.97 6 3.51 17.22 6 2.72 24.76 6 5.94 18.27 6 3.37
IL-2Rc 95.58 6 6.70 27.18 6 5.90 84.74 6 5.53 24.79 6 2.33
IL-4Ra 64.07 6 10.33 57.10 6 9.77 58.71 6 8.17 49.00 6 3.01
IL-15Ra 32.69 6 12.28 25.00 6 6.97 35.41 6 13.79 26.18 6 8.27
aThese data summarize the expression of cC cytokine receptor in four individuals as measured by ﬂow cytometry.
bAverage % cytokine receptor expression 6 standard deviations of the mean.
cAverage MFI: mean ﬂuorescence intensity 6 standard deviations of the mean.
Fig. 1. Cell gating strategy for the analysis of cell division by ﬂow
cytometry. Isolated CD8
+CD127
+ and CD8
+CD127
 T cells were
stained with CFSE and then cultured for 4 days before analysis.
Activated and/or dividing lymphocytes within the isolated subsets
were identiﬁed on the basis of increased forward and side scatter
proﬁles (R1) relative to the proportionally smaller non-dividing cells.
Approximately 10 000 total cells were analyzed for each sample.
Representative scatter plots of (A) untreated CD8
+ T cells and (B)
CD8
+ Tcells treated with a submaximal concentration of PHA (2.5 lg
ml
1). Cells within the R1 gate (1000–5000 cells) were then gated into
CD8
+CD45RA
+ and CD8
+CD45RA
 subsets for cell division analysis.
(C) A representative histogram of gated CD8
+ T cells depicts cell
frequencies versus CFSE staining. Markers delineating cell divisions
are included. A bracket delineates cells that have undergone >3
divisions, i.e. ‘CFSE
lo’ cells. This histrogram displays the CFSE proﬁle
of colchicine-treated (mitotically arrested) cells (black), cells stimu-
lated with submaximal (white) and maximal (gray, 10 lgm l
1)
concentrations of PHA and non-CFSE-labeled cells (dotted line).
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+/ T cellsSimilarly, IL-2 (1, 10 and 100 units ml
1) increased the pro-
portion of CFSE
lo cells (P < 0.001 compared with PHA
alone). IL-4 did not increase the proportions of CFSE
lo cells
in this subset. Thus, IL-2 and -15, but not IL-4, signiﬁcantly
increased the proportions of PHA-stimulated
CD127
CD45RA
+ T cells undergoing multiple cell divisions.
Cell division of CD8
+CD127
CD45RA
 T cells (TE/
TEM). Incubation of CD8
+CD127
CD45RA
 T cells with PHA
signiﬁcantly increased the proportion of CFSE
lo cells (Fig.
3D). Low concentrations of IL-4 (1 and 10 ng ml
1) tended
to increase the proportion of CFSE
lo cells, although this did
not reach statistical signiﬁcance (P = 0.061 and 0.058, re-
spectively); however, 100 ng ml
1 of IL-4 increased the pro-
portion of CFSE
lo cells (P = 0.035) compared with PHA
alone. This appears to be in contrast to the lack of IL-4-
induced proliferation in bulk CD8
+CD127
 T cells (Fig. 2).
This is likely due to the fact that CD8
+CD127
CD45RA

T cells make up <15% of all CD8
+CD127
 T cells (data not
shown), and hence this proliferative effect may not be
detected when analyzing bulk CD127
 T cells. In contrast,
IL-2 or IL-15 did not signiﬁcantly increase the proportion of
CFSE
lo cells. Therefore, IL-4, but not IL-2 and IL-15, in-
creased the proportion of CD127
CD45RA
 T cells undergo-
ing multiple cell divisions. Analyses of these data for all
dividing cells (i.e. not just those that have divided three or
more times) yielded similar results (data not shown).
Susceptibility to apoptosis
Human CD8
+CD127
+ T cells are known to undergo less
spontaneous apoptosis than CD8
+CD127
 T cells (19); how-
ever, the role of cC cytokines in regulating cell death (an im-
portant function of these cytokines) in these subsets has not
been described. It should be noted that there were consis-
tently more (>2-fold) Annexin–V
+PI
+ cells (apoptotic or ne-
crotic cells) in the CD8
+CD127
 T cells compared with the
CD8
+CD127
+ T cells at the initiation of culture and this was
consistent following 4 days of culture (Fig. 4A and B). In ad-
dition, a greater proportion of CD8
+CD127
 T cells were
spontaneously apoptotic (Annexin
+PI
) compared with
CD8
+CD127
+ T cells (P = 0.010, Fig. 4C and D) as
expected. The cytokines tested included IL-2 and IL-15 due
to their common and distinct roles in T cell survival (10). The
results are described below in detail and are summarized in
Figs 4 and 5 and Table 2.
Apoptosis of CD8
+CD127
+ T cells. When CD8
+CD127
+
T cells were incubated with anti-CD3, the proportion of
Annexin–V
+PI
 cells and caspase-3 and caspase-8 activity
increased signiﬁcantly compared with unstimulated cells
(P = 0.051, Figs 4C, 5A and C). Incubation with anti-Fas in-
creased Annexin–V
+PI
 staining (P = 0.036) but had no ef-
fect on caspase activity. Pre-incubation of CD8
+CD127
+
T cells with IL-2 signiﬁcantly reduced the proportion of
Annexin–V
+PI
 cells, caspase-3 and caspase-8 activity in-
duced by anti-CD3 (P = 0.001, 0.006 and 0.050, respec-
tively Figs 4C, 5A and C). Similarly, IL-2 decreased
Annexin–V
+PI
 cells and caspase-8 in anti-Fas-stimulated
cells (P = 0.045 and 0.027, respectively, Figs 4C and 5A)
but increased caspase-3 activity (Fig. 5C). Pre-treatment
with IL-15 did not alter Annexin–V
+PI
 staining in response
to anti-CD3 but it did decrease caspase-3 and caspase-8
activity (P = 0.010 and 0.048, Figs 4E and 5C). The effects
of IL-15 on anti-Fas-induced apoptosis were inconsistent:
Fig. 2. Cell division of CD8
+CD127
+ and CD8
+CD127
 Tcells in response to cC cytokines. Isolated CD8
+CD127
+ and CD8
+CD127
 Tcells were
cultured with media only (Ctl) and cells incubated with PHA (2.5 lgm l
1), PHA + IL-4 (1, 10 or 100 ng ml
1) or PHA + IL-15 (10 ng ml
1) or PHA +
IL-2 (1, 10 or 100 units ml
1). Representative dot plots of cell division proﬁles of CD8
+ T cell subsets are shown: (A) CD8
+CD127
+ and (B)
CD8
+CD127
. The CFSE
lo cells (shown in hatched boxes), have undergone >3 divisions. The cytokine concentrations shown here include IL-4
(100 ng ml
1), IL-15 (10 ng ml
1) and IL-2 (100 units ml
1). In addition, the proportion of CFSE
lo cells from experiments in six individuals is
summarized in bar graphs. Statistically signiﬁcant changes in the proportion of CFSE
lo cells are indicated with a ‘z’ compared with unstimulated
controls (Ctl) or ‘*’ when comparing PHA + IL-4 (paired Student’s t-test, P < 0.05), IL-15 or IL-2 to PHA alone.
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+PI
 staining and caspase-3
activity while decreasing caspase-8 activity. Therefore, in
CD8
+CD127
+ T cells, IL-2 was more protective against anti-
Fas- and anti-CD3-induced apoptosis while IL-15 seemed
only to have a protective effect by decreasing caspase ac-
tivity in anti-CD3-stimulated cells.
Apoptosis of CD8
+CD127
 T cells. Incubation of
CD8
+CD127
 T cells with anti-CD3 resulted in an increase in
Annexin–V
+PI
 staining (P = 0.021, Fig. 4D and F) but incu-
bation with anti-Fas did not. Similar to CD8
+CD127
+ T cells,
pre-treatment of CD8
+CD127
 T cells with IL-2 decreased
Annexin–V
+PI
 staining induced by anti-CD3 but increased
the effect of anti-CD3 or anti-Fas on caspase-3 activity
(P = 0.050, Fig. 5D). Pre-treatment with IL-15 decreased
caspase-8 activity of both anti-CD3- and anti-Fas-stimulated
CD8
+CD127
 T cells, but increased anti-Fas-induced
Annexin–V
+PI
 staining and had no effect on caspase-3 ac-
tivity (Figs 4F and 5D). IL-15 decreased caspase-8 activity
in anti-CD3-stimulated cells but had no effect on Annexin–
V
+/PI
 staining or caspase-3 activity. Therefore, pre-treat-
ment of CD8
+CD127
 T cells with either IL-2 or IL-15 did not
consistently decrease anti-Fas- or anti-CD3-induced apopto-
sis, and in some cases, cytokine pre-treatment resulted in
an increase in apoptosis-related signals.
Analysis of the data for ‘dead or dying’ cells (i.e. Annexin–V
+
or PI
+ cells per all cells) yielded similar results. Therefore,
exclusion of dead (PI
+) cells from the analysis did not signiﬁ-
cantly bias the results.
Expression of Bcl-2 and phospo-STAT5
Cell death signals are counterbalanced by survival signals
provided to a cell. Since the anti-apoptotic molecule Bcl-2
has an important role in reducing a cell’s susceptibility to ap-
optosis (35), the expression of Bcl-2 in isolated CD8
+CD127
+
and CD8
+CD127
 T cells was investigated. In these experi-
ments, IL-2 was included due to its dual role in cell prolifera-
tion and activation-induced cell death and IL-15 was used
as it has primarily been associated with cell survival. There
was no statistically signiﬁcant difference in the amount of
Fig. 3. Cell division of subsets of CD8
+CD127
+ and CD8
+CD127
 T cells. Isolated CD8
+CD127
+ and CD8
+CD127
 T cells were cultured with
media only (Ctl) and cells incubated with PHA (2.5 lgm l
1), PHA + IL-4 (1, 10 or 100 ng ml
1) or PHA + IL-15 (10 ng ml
1) or PHA + IL-2 (1, 10 or
100 units ml
1). Representative dot plots (y-axis, CD8
+: x-axis, CFSE) of cell division proﬁles of CD8
+ T cell subsets are shown: (A)
CD127
+CD45RA
+, (B) CD127
+CD45RA
, (C) CD127
CD45RA
+ and (D) CD127
CD45RA
. The CFSE
lo cells (shown in hatched boxes) have
undergone the maximum number of detectable divisions. The cytokine concentrations shown here include IL-4 (100 ng ml
1), IL-15 (10 ng ml
1)
and IL-2 (100 units ml
1). In addition, the proportion of CFSE
lo cells from experiments in six individuals is summarized in bar graphs. Statistically
signiﬁcant changes in the proportion of CFSE
lo cells are indicated with a ‘z’ compared with unstimulated controls (Ctl) or ‘*’ when comparing PHA
+ IL-4 (paired Student’s t-test, P < 0.05), IL-15 or IL-2 to PHA alone.
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+CD127
+/ T cellsthe anti-apoptotic molecule Bcl-2 expressed in unstimulated
CD8
+CD127
+ T cells compared with CD8
+CD127
 T cells
(Fig. 6A) which concurs with previous ﬁndings (36). Dispa-
rate production of Bcl-2 between these subsets has been
reported in the context of antigen or IL-7 stimulation or spe-
ciﬁc diseases (21, 36, 37). Incubation of CD8
+CD127
+ Tc e l l s
with IL-2 or IL-15 signiﬁcantly increased Bcl-2 expression by
2.8-fold (P < 0.001) and 3.9-fold (P < 0.001), respectively,
compared with medium controls. An increase in Bcl-2 expres-
sion in CD8
+CD127
 T cells incubated with IL-2 or IL-15 was
also observed though was somewhat lower (increases of 2.2-
and 3.2-fold, respectively; P < 0.0001). The amount of Bcl-2
produced in CD8
+CD127
+ T cells in response to IL-2 or IL-15
was signiﬁcantly greater than in CD8
+CD127
 T cells
(P = 0.002 and 0.012, respectively). Thus, although these
two subsets do not signiﬁcantly differ in their basal level of
Fig. 4. Apoptosis in isolated CD8
+CD127
 and CD8
+CD127
+ T cells pre-incubated with IL-2 or IL-15. (A and B) Isolated CD8
+CD127
+ and
CD8
+CD127
 Tcells were cultured with media only for 4 days, stained for Annexin–V/PI and analyzed by ﬂow cytometry. The dot plots represent
the percentage staining of Annexin–V (x-axis) versus PI (y-axis). The proportion of cells that are either apoptotic or necrotic (Annexin–V
+PI
+ or
Annexin–V
PI
+, circled with a dotted line) and are hence indistinguishable from truly apoptotic cells (Annexin–V
+PI
). These results were
conﬁrmed on a total of six separate experiments. (C–F) Isolated CD8
+CD127
+ and CD8
+CD127
 Tcells were cultured with medium only (Ctl), IL-2
[100lml
1 (C) and (D)] or IL-15 [100 ng ml
1 (E) and (F)] for 48 h followed by a 48-h incubation with anti-Fas (3.3 lgm l
1) or anti-CD3 (1 lgm l
1)
to induce apoptosis. Apoptotic cells (Annexin–V
+PI
) were detected by ﬂow cytometry and their proportions were calculated using the
following formula: % of Annexin–V
+PI
 cells/(% Annexin–V
+PI
 cells + % Annexin–V
PI
 cells). Statistically signiﬁcant effects are indicated with
a‘ *’ compared with Ctl or ‘**’ when comparing anti-Fas or anti-CD3 alone compared with anti-Fas or anti-CD3 + IL-2 or IL-15 (Student’s t-test P <
0.05, n = 6).
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+CD127
+ T cells are more responsive to
IL-2 or IL-15 than CD8
+CD127
 T cells in this regard.
The expression of Bcl-2 by several cC cytokines is increased
in part by signaling pathways that phosphorylate STAT pro-
teins (38). The intracellular expression of phosphorylated-
STAT5, a signaling molecule induced by IL-2 and IL-15, was
assessed by ﬂow cytometry. Culturing CD8
+CD127
+ Tc e l l s
with IL-2 (100 units ml
1) or IL-15 (100 ng ml
1) induced
more phospho-STAT5 than CD8
+CD127
 T cells (Fig. 6B).
This may explain in part the discrepancies in the magnitude
Fig. 5. Caspaseactivity of CD8
+CD127
+ and CD8
+CD127
 Tcells pre-incubated with IL-2 or IL-15. Cells were treated with medium only (Ctl), IL-2
(100 l ml
1) or IL-15 (100 ng ml
1) for 48 h followed by a 48-h incubation with anti-Fas (3.3 lgm l
1) or anti-CD3 (1 lgm l
1) to induce apoptosis
and caspase-3 and -8 activity were evaluated by ﬂow cytometry. Caspase-8 activity was measured in A) CD8
+CD127
+ and B) CD8
+CD127

T-cells and caspase-3 activity was measured in C) CD8
+CD127
+ and D) CD8
+CD127
 T-cells. Data are represented as relative caspase
activity. Statistically signiﬁcant effects are indicated by ‘*’ when compared with Ctl or ‘**’ when comparing anti-Fas or anti-CD3 + IL-2 or IL-15 and
anti-Fas or anti-CD3 alone (Student’s t-test P < 0.05, 6SD, n = 4).
Table 2. Summary of statistically signiﬁcant
a apoptosis-related features of CD8
+CD127
+ and CD8
+CD127
 T cells
b
CD8
+CD127
+ CD8
+CD127

Annexin
+ Caspase-8 Caspase-3 Annexin
+ Caspase-8 Caspase-3
IL-2 Y NC [ NC [[
IL-15 NC [[NC NC Y
Anti-CD3 [ [[[ NC Y
Anti-Fas [ NC NC NC NC Y
IL-2 + anti-CD3 Y YYY NC [
IL-2 + anti-Fas YY [ NC [[
IL-15 + anti-CD3 NC YYNC Y NC
IL-15 + anti-Fas [ Y[[ YNC
NC, no change;[ = signiﬁcantly increases apoptosis (P < 0.05); Y = signiﬁcantly decreases apoptosis (P < 0.05).
aStatistical signiﬁcance was determined by the Student’s t-test (P < 0.05).
bResponses to cytokine, anti-CD3 or anti-Fas alone were compared with medium controls while responses involving cytokine pre-treatment
followed by anti-Fas or anti-CD3 were compared with anti-Fas or anti-CD3 alone.
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+CD127
+/ T cellsof Bcl-2 expression by the two cell subsets in response to
IL-2 or IL-15.
Expression of Fas, phospho-FOXO3a and phospho-Akt
One of the most common pathways used by cytotoxic effector
T cells is initiated by Fas signaling (39, 40). To determine if
CD8
+CD127
+ and CD8
+CD127
 T cell subsets differ in their
potential susceptibility to receptor-mediated apoptosis, the
expression of the Fas receptor was analyzed. Isolated
CD8
+CD127
 T cells expressed signiﬁcantly more Fas than
CD8
+CD127
+ Tc e l l s( P = 0.0003, Fig. 7) and concurs with re-
cent ﬁndings that suggest a similar dichotomy of Fas expres-
sion among T cell subset in the context of CD127 expression
(41). These results suggest that cytotoxic effector CD8
+
T cells, which are typically CD127
, express more Fas than
non-cytotoxic CD8
+ T cells. However, in these experiments,
subset differences in susceptibility to anti-Fas-induced apo-
ptosis were inconsistent as the observed anti-Fas effects
were relatively weak and variable in isolated CD8
+CD127
+
and CD8
+CD127
 T cells (Figs 4 and 5; Table 2).
Baseline anti-apoptotic phospho-FOXO3a expression was
assessed by western blot. Isolated CD8
+CD127
+ T cells
expressed more phospho-FOXO3a compared with
CD8
+CD127
 T cells (Fig. 7B). This compliments the ob-
served increase in spontaneous apoptosis in CD8
+CD127

T cells (Fig. 4B). Differences in cytokine-induced proliferation
may be due to altered activation of phospho-Akt, a mitogen-
activated protein kinase pathway molecule common to cC
cytokines and important for T cell proliferation (42). The IL-2,
IL-4 and IL-15 cytokines induced a higher level of phosphor-
ylated Akt in CD8
+CD127
+ T cells than in CD8
+CD127

T cells (Fig. 7C). This may explain observed proliferation pat-
terns to cytokines such as the increase in IL-4- and IL-15-
induced proliferation of CD8
+CD127
+ T cells compared with
CD8
+CD127
 T cells (Fig. 2).
Discussion
The present study is the ﬁrst to directly compare the cell di-
vision and susceptibility to apoptosis of human CD8
+CD127
+
and CD8
+CD127
 T cells in response to cC cytokines. It has
been hypothesized that regaining or maintaining the expres-
sion of CD127 and increased Bcl-2 expression through the
effector stage may result in the generation of long-lived
memory cells while lack of CD127 predicts cell death (43,
44). This has also been associated with IL-7- and IL-15-
dependent production of long-term memory CD8
+ T cells
(45). A recent report has shown that when cultured with
IL-7, naive CD8
+ T cells enter the cell cycle with delayed
kinetics compared with memory cells (46). Despite this de-
lay, continuous IL-7 stimulation caused a signiﬁcantly greater
number of naive cells to divide for a longer period of time
than memory CD8
+ T cells that tended to exit the cell cycle
Fig. 6. The expression of Bcl-2 in CD8
+CD127
+ T cells and CD8
+CD127
 T cells in response to IL-2 or IL-15. (A) Representative ﬂow cytometry
histograms depict the expression of Bcl-2 by isolated CD8
+CD127
+ and CD8
+CD127
 Tcells cultured for 48 h with medium only (Ctl, white ﬁll), IL-2
(100 units ml
1, gray ﬁll) or IL-15 (100 ng ml
1, black ﬁll). Unstained cells (similar to isotype control) are shown with a dotted line, proximal to the
y-axis. The expression of Bcl-2 in these two subsets in six individuals is expressed as mean ﬂuorescence intensities (MFI). Statistically signiﬁcant
differences compared with Ctl are indicated with ‘*’ (Student’s t-test P < 0.05, 6SD). (B) The expression of phosphorylated STAT5 in CD8
+CD127
+
and CD8
+CD127
 T cells cultured for 15 min with IL-2 (100 units ml
1) or IL-15 (100 ng ml
1) is shown in ﬂow cytometry histograms. Mean
ﬂuorescence intensity values are indicated. Data represent the results from one of four individuals tested.
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regulates CD127 expression on CD8
+ T cells in both mice
(47) and humans (25, 46, 48–50), and this may impede the
delivery of signals for cell survival and memory cell develop-
ment. However, a recent report has shown that CD127 ex-
pression is insufﬁcient to reduce cell death in the
contraction phase, and that CD127 expression does not
necessarily preclude susceptibility to apoptosis (51). This
supports the notion that cC cytokines other than IL-7 may de-
termine the fate of effector cells.
Isolated CD8
+CD127
 T cells from healthy individuals
were recently shown to be more susceptible to apoptosis
than CD8
+CD127
+ T cells, as reported herein (Figs 4 and 5;
Table 2), and this difference was enhanced in HIV-infected
individuals (19). The mechanisms responsible for these ob-
served differences in apoptosis in CD8
+ T cells are unclear.
We have reported for the ﬁrst time that CD8
+CD127
 T cells
express signiﬁcantly more Fas than CD8
+CD127
+ T cells
(Fig. 7A) which may explain this ﬁnding. However, in the
present experiments, there was no difference between the
susceptibility of CD8
+CD127
+ T cells versus CD8
+CD127

T cells to Fas-induced apoptosis, questioning the signiﬁ-
cance of differential Fas expression in these subsets. We
demonstrated that CD8
+CD127
 T cells are more prone to
spontaneous apoptosis than CD8
+CD127
+ T cells (Fig. 4).
This may be explained by CD8
+CD127
 T cells’ lower ex-
pression of anti-apoptotic molecule FOXO3a (Fig. 7B), a mol-
ecule associated with promoting memory T cell longevity
(52) and resistance to apoptosis in HIV
+ elite controllers
(53). The greater amount of Bcl-2 in CD8
+CD127
+ T cells
and the incremental cytokine-increased Bcl-2 expression
suggests that this subset would be less prone to apoptosis than
CD8
+CD127
 T cells (Fig. 6A). Increased cytokine-induced
phosphorylation of STAT5 in CD8
+CD127
+ T cells may be
a mechanism underlying the subset differences in Bcl-2 ex-
pression (Fig. 6B) as STAT5 phosphorylation has been
shown to increase Bcl-2 transcription (38). However, not all
forms of apoptotic stimuli are inhibited by Bcl-2, which acts
primarily on mitochondrial-associated apoptosis and does
not inhibit Fas-mediated apoptosis (54).
In the present report, IL-2 and IL-15 signaling seemed to
decrease the effects of anti-Fas/anti-CD3-induced apoptosis
in CD8
+CD127
+ T cells while CD8
+CD127
 T cells were less
responsive to the anti-apoptotic effects of these cytokines
(Table 2). Although IL-2 and IL-15 employ the same b and c
receptors (55), they have distinct roles in inhibiting and pro-
moting CD8
+ T cell survival, respectively (13, 56). IL-15 is
largely known for its proliferative and anti-apoptotic effects.
We observed that pre-incubation with IL-15 decreased cas-
pase-8 activity in CD8
+CD127
+ and CD8
+CD127
 T cells in
response to anti-Fas but increased Annexin–V
+PI
 staining
and caspase-3 activity (Table 2). A previous report showed
that IL-15-stimulated lymphocytes are rendered more sus-
ceptible to apoptosis compared with lymphocytes stimulated
with IL-2 (57) and this is conﬁrmed here in CD127
+ T cells
treated with IL-15 only (Fig. 5A). In addition, IL-15-induced
Fig. 7. Expression of Fas on CD8
+CD127
 T cells and CD8
+CD127
+ T cells. (A) A representative ﬁgure of Fas expression on freshly isolated
CD8
+CD127
+ (gray line) and CD8
+CD127
 T cells (black line) as evaluated by ﬂow cytometry. Unstained cells are shown in black ﬁll. The
expression of Fas is graphed as % Fas-positive cells within isolated CD8
+CD127
+ and CD8
+CD127
 Tcells. Statistical signiﬁcance is denoted by
‘*’ as calculated by analysis of variance analysis (P < 0.05, n = 7). (B) The baseline expression of phosphorylated FOXO3a by CD8
+CD127
+ and
CD8
+CD127
 T cells is shown by western blot analysis, depicting the results of two individuals as representatives of six individuals tested. The
expression of FOXO1 was also detected by the FOXO-speciﬁc antibody. The expression of beta-actin was used as a loading control. (C) The
expression of phosphorylated-Akt CD8
+CD127
+ and CD8
+CD127
 Tcells cultured for 2 h with medium, IL-2 (100 units ml
1), IL-4 (100 ng ml
1)
or IL-15 (100 ng ml
1) is shown by western blot. The data represent the results of one individual as a representative of four individuals tested.
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total number of apoptotic cells, particularly with high con-
centrations of cytokine (57) as used here. Similarly, the in-
duction of caspase activity by IL-2 in CD8
+CD127
 T cells
may be in part due to IL-2’s reportedly potent ability to both
induce proliferation while increasing susceptibility to apopto-
sis and suggests that this cell subset is more susceptible to
apoptosis than CD8
+CD127
+ T cells (11).
To facilitate the evaluation of cytokine effects, isolated
CD8
+CD127
+ and CD8
+CD127
 T cells were treated with
submaximal concentrations of PHA (2.5 lgm l
1). There was
no quantitative difference in the proportion of cells undergo-
ing multiple divisions (% CFSE
lo cells) between these two
populations when incubated with this concentration of PHA.
This would appear to be in contrast to a previous report in
which a high concentration of PHA (10 lgm l
1) signiﬁcantly
increased CD8
+CD127
+ T cell division compared with
CD8
+CD127
 T cells (19). We report that IL-2, IL-4 and IL-
15 enhance the proliferation of CD8
+CD127
+ T cells while
only IL-2 and IL-15 enhance CD8
+CD127
 T cell division
(Fig. 5). We further subdivided these two populations into
speciﬁc subsets. Phenotypic and functional characteristics
of CD8
+CD127
+ and CD8
+CD127
 T cells suggest that Tnaive
and TCM cells are CD8
+CD127
+ while effector cells (includ-
ing TEM and TEMRA) are mostly CD8
+CD127
 (19). Speciﬁ-
cally, the pattern of CD127 and CD45RA expression
has been associated with distinct CD8
+ T cell subsets
(58). Therefore, for the evaluation of cC cytokine-induced cell
division, these markers were used here to distinguish be-
tween Tnaive,T E/EM,T EMRA and TCM CD8
+ T cells, all of which
are known to have both redundant and unique cytokine
requirements for proliferation (13). For the purpose of
discussion, cell subsets are referred to according to cell
surface markers based on T cell phenotypes published
previously (14–16): naive cells (CD8
+CD127
+CD45RA
+),
effector cells (CD8
+CD127
CD45RA
), memory cells
(CD8
+CD127
+CD45RA
) and RA
+ effector–memory-like cells
(CD8
+CD127
CD45RA
+). Although there may be limitations
to this phenotyping of T cells, there is sufﬁcient rationale to
suggest that the expression of CD127 identiﬁes phenotypi-
cally and functionally distinct cell subsets (19). We have pre-
viously shown that the majority of CD8
+CD127
+CD45RA
+
T cells derived from PBMC is naive, i.e. CD62L
+ (48). We ob-
served that when stimulated PHA in the presence or ab-
sence of cytokines, both CD8
+CD127
+ and CD8
+CD127

T cells decreased the intensity of CD45RA expression while
still remaining CD45RA
+ and this was associated with in-
creased cell division (data not shown). This would not ap-
preciably affect the analysis of cell subsets using the above
strategy. It is also acknowledged that the CD8
+CD127
+ T cell
subset is a heterogenous population of naive and TCM cells,
the latter of which may respond more rapidly to proliferative
signals and subsequently produce cytokines that could
affect the naive T cells.
Interestingly, cell division responses to IL-2, IL-4 or IL-15
preferentially enhance the cell division of the two effector
Fig. 8. A model for the cell division and susceptibility to apoptosis of CD8
+CD127
+ and CD8
+CD127
 T cell subsets. The present ﬁndings,
identiﬁed by text boxes with small dotted lines, have been inserted into a version of the currently accepted model for three main elements of
a CD8
+ T cell response (1). T cell activation results in the down-regulation of CD127 on naive CD8
+CD127
+ T cells and their susceptibility to
apoptosis is inhibited by IL-2 and IL-15, resulting in the expansion of CD8
+CD127
CD45RA
 effector Tcells which can be enhanced by IL-4 (2).
The signals, that either inhibit the apoptosis of the majority of the effector cells or ensure the survival of remaining cells (5%) into memory cells
following the contraction phase, are unclear (3). The expansion of activated central memory cells (CD8
+CD127
+CD45RA
) is enhanced by IL-4 or
IL-15 while activated effector–memory cells (CD8
+CD127
CD45RA
+) divide in response to IL-15. This model does not describe CD8
+ T cell
development as a linear event as suggested by the potential for the differentiation of naive CD8
+ Tcells into either central or RA
+ effector–memory
cells shown with dashed arrows. Cells undergoing apoptosis are identiﬁed by a cross symbol.
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+CD127
 T cells with IL-4 en-
hanced the proportion of CFSE
lo effector CD8
+ T cells
(CD127
CD45RA
) while neither IL-2 nor IL-15 had any sig-
niﬁcant effects (Fig. 3). In contrast, both IL-2 and IL-15 in-
creased the proportion of CFSE
lo TEMRA cells while IL-4 had
no signiﬁcant effect. These results cannot be explained by
cytokine receptor expression since the expression of IL-2Rb,
IL-2Rc, IL-4Ra and IL-15Ra is similar in CD8
+CD127
+ and
CD8
+CD127
 T cells (Table 1). It is possible that proliferation
differences are due in part to CD8
+CD127
 T cells’ in-
creased magnitude of cytokine-induced phosphorylation of
Akt (Fig. 7C), suggesting inherent subsets differences in sig-
naling pathways associated with proliferation (38, 42). The
present data indicate some signiﬁcant dose responses
to cytokine treatment; however, it appears that despite the
titrations used here, there was not always a consistent
dose-dependent proliferation response. This is not the ﬁrst
occasion in which a cytokine dose response could not be ti-
trated. For example, STAT5 signaling in CD8
+ T cells, com-
mon to many cC cytokines, appears to require a threshold of
cytokine to induce detectable signal and increasing signal-
ing strength is indistinguishable when higher concentrations
of cytokines are used (A. M. Crawley, S. Faucher, J. B. An-
gel, unpublished results).
Based on currently accepted models of CD8
+ T cell acti-
vation and differentiation and the present ﬁndings, we
propose a revised model regarding the survival and suscep-
tibility to apoptosis of CD8
+CD127
+ and CD8
+CD127
 T cell
subsets (Fig. 8). Activated CD8
+ Tnaive cells respond to IL-2
signaling and will differentiate into effector cells which then
clonally expand in response to IL-2 or IL-4. The factors regu-
lating the survival of developing memory cells from effector
cells following the contraction phase are not known. Lastly,
IL-2, IL-4 or IL-15 can enhance the expansion of activated
CD8
+ TCM cells and resistance of these cells to apoptosis is
augmented by IL-2 or IL-15.
Collectively, these data indicate that CD8
+CD127
+ T cells
are more consistently responsive to the anti-apoptotic effects
of IL-2 and IL-15 than CD8
+CD127
 T cells. In addition, the
cell division kinetics of cells expressing or lacking CD127 dif-
fer in response to IL-2, IL-4 or IL-15. The frequency of cell di-
vision may relate to different functional characteristics of
CD8
+ T cells, although this has not yet been described.
These results are of particular relevance for diseases in
which the expression of CD127 is altered. The expression of
CD127 is down-regulated in several viral infections, and in
HIV infection this parallels disease progression (22–24, 26).
In breast cancer patients, down-regulation of CD127 expres-
sion on CD8
+ T cells is associated with decreased expres-
sion of STAT5, a signaling molecule shared by other cC
cytokines (59). Mechanisms responsible for the homeostatic
maintenance and proliferation of T cells within a full T cell
compartment are now known to differ from T cell restoration
in response to acute T-lymphopenia as seen in progressive
HIV infection where responsiveness to survival cytokines
such as IL-7 is compromised (60, 61). This may be explained
in part by different T cell responses to cytokine survival and
proliferation signals (27) and as described here, with the dif-
ferential effects of IL-2, -4 and -15 on CD8
+ T cell subset sur-
vival features. Understanding cell survival and differentiation
signals is of the utmost importance for the design of thera-
pies meant to improve CD8
+ T cell responses, including ther-
apeutics that consist of exogenous cytokines.
Funding
Ontario HIV Treatment Network (ROGB131); Canadian Insti-
tutes of Health Research (HOP84649).
Acknowledgements
The authors thank Drs Paul MacPherson and Ashok Kumar for helpful
discussion and critical review of the manuscript. A.M.C. is a recipient
of an Ontario HIV Treatment Network (OHTN) fellowship and J.B.A. is
an OHTN Career Scientist.
Contribution: A.M.C. designed and performed most of the research,
analyzed data and wrote the paper; T.K. performed a number of the
experiments; K.P. assisted with the ﬂow cytometry analysis and J.B.A.
assisted in the design of the research, data analysis and aided in the
writing of the paper. The authors also gratefully acknowledge James
MacLeod for his assistance with some of these experiments.
Conﬂict-of-interest disclosure: The authors declare no competing
ﬁnancial interests.
Abbreviations
CFSE carboxyﬂuorescein succinimdyl ester
FAM carboxyﬂuorescein
FMK ﬂuoromethyl ketone
PI phosphatidylinositol
cC c chain
References
1 Ziegler, S. E., Morella, K. K., Anderson, D. et al. 1995.
Reconstitution of a functional interleukin (IL)-7 receptor demon-
strates that the IL-2 receptor gamma chain is required for IL-7
signal transduction. Eur. J. Immunol. 25:399.
2 Fry, T. J. and Mackall, C. L. 2005. The many faces of IL-7: from
lymphopoiesis to peripheral T cell maintenance. J. Immunol.
174:6571.
3 Schluns, K. S., Kieper, W. C., Jameson, S. C. and Lefrancois, L.
2000. Interleukin-7 mediates the homeostasis of naive and
memory CD8 T cells in vivo. Nat. Immunol. 1:426.
4 Benczik, M. and Gaffen, S. L. 2004. The interleukin (IL)-2 family
cytokines: survival and proliferation signaling pathways in
T lymphocytes. Immunol. Invest. 33:109.
5 Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J. and Surh,
C. D. 2002. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic
proliferation of memory phenotype CD8+ cells but are not required
for memory phenotype CD4+ cells. J. Exp. Med. 195:1523.
6 Schluns, K. S., Williams, K., Ma, A., Zheng, X. X. and Lefrancois, L.
2002. Cutting edge: requirement for IL-15 in the generation of
primary and memory antigen-speciﬁc CD8 T cells. J. Immunol.
168:4827.
7 Li, X. C., Demirci, G., Ferrari-Lacraz, S. et al. 2001. IL-15 and IL-2:
a matter of life and death for T cells in vivo. Nat. Med. 7:114.
8 Riou, C., Dumont, A. R., Yassine-Diab, B., Haddad, E. K. and
Sekaly, R. P. 2006. IL-4 inﬂuences the differentiation and the
susceptibility to activation-induced cell death of human naive
CD8+ T cells. Int. Immunol. 18:827.
9 Berard, M., Brandt, K., Bulfone-Paus, S. and Tough, D. F. 2003. IL-
15 promotes the survival of naive and memory phenotype CD8+
T cells. J. Immunol. 170:5018.
10 Ma, A., Koka, R. and Burkett, P. 2006. Diverse functions of IL-2, IL-
15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24:657.
11 Lenardo, M., Chan, K. M., Hornung, F. et al. 1999. Mature
T lymphocyte apoptosis—immune regulation in a dynamic and
unpredictable antigenic environment. Annu. Rev. Immunol.
17:221.
40 Division and apoptosis of CD8
+CD127
+/ T cells12 Sun, J. C., Lehar, S. M. and Bevan, M. J. 2006. Augmented IL-7
signaling during viral infection drives greater expansion of effector
T cells but does not enhance memory. J. Immunol. 177:4458.
13 Schluns, K. S. and Lefrancois, L. 2003. Cytokine control of memory
T-cell development and survival. Nat. Rev. Immunol. 3:269.
14 Geginat, J., Lanzavecchia, A. and Sallusto, F. 2003. Proliferation
and differentiation potential of human CD8+ memory T-cell
subsets in response to antigen or homeostatic cytokines. Blood
101:4260.
15 Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A.
1999. Two subsets of memory T lymphocytes with distinct homing
potentials and effector functions. Nature 401:708.
16 Wherry, E. J., Teichgraber, V., Becker, T. C. et al. 2003. Lineage
relationship and protective immunity of memory CD8 T cell
subsets. Nat. Immunol. 4:225.
17 Huster, K. M., Busch, V., Schiemann, M. et al. 2004. Selective
expression of IL-7 receptor on memory T cells identiﬁes early
CD40L-dependent generation of distinct CD8+ memory T cell
subsets. Proc. Natl Acad. Sci. USA 101:5610.
18 Bachmann, M. F., Wolint, P., Schwarz, K., Jager, P. and Oxenius,
A. 2005. Functional properties and lineage relationship of CD8+
T cell subsets identiﬁed by expression of IL-7 receptor alpha
and CD62L. J. Immunol. 175:4686.
19 Paiardini, M., Cervasi, B., Albrecht, H. et al. 2005. Loss of CD127
expression deﬁnes an expansion of effector CD8+ T cells in HIV-
infected individuals. J. Immunol. 174:2900.
20 Zaunders, J. J., Moutouh-de Parseval, L., Kitada, S. et al. 2003.
Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes
during primary human immunodeﬁciency virus type 1 infection:
regulation by interleukin (IL)-2, IL-15, and Bcl-2. J. Infect. Dis.
187:1735.
21 Lang, K. S., Recher, M., Navarini, A. A. et al. 2005. Inverse
correlation between IL-7 receptor expression and CD8 T cell
exhaustion during persistent antigen stimulation. Eur. J. Immunol.
35:738.
22 Koesters, S. A., Alimonti, J. B., Wachihi, C. et al. 2006. IL-7Ralpha
expression on CD4(+) T lymphocytes decreases with HIV disease
progression and inversely correlates with immune activation. Eur.
J. Immunol. 36:336.
23 Boutboul, F., Puthier, D., Appay, V. et al. 2005. Modulation of
interleukin-7 receptor expression characterizes differentiation of
CD8 T cells speciﬁc for HIV, EBV and CMV. AIDS 19:1981.
24 Golden-Mason, L., Burton, J. R. Jr, Castelblanco, N. et al. 2006.
Loss of IL-7 receptor alpha-chain (CD127) expression in acute
HCV infection associated with viral persistence. Hepatology
44:1098.
25 Sasson, S. C., Zaunders, J. J., Zanetti, G. et al. 2006. Increased
plasma interleukin-7 level correlates with decreased CD127 and
increased CD132 extracellular expression on T cell subsets in
patients with HIV-1 infection. J. Infect. Dis. 193:505.
26 MacPherson, P. A., Fex, C., Sanchez-Dardon, J., Hawley-Foss, N.
and Angel, J. B. 2001. Interleukin-7 receptor expression on
CD8(+) T cells is reduced in HIV infection and partially restored
with effective antiretroviral therapy. J. Acquir. Immune Deﬁc.
Syndr. 28:454.
27 Goldrath, A. W., Sivakumar, P. V., Glaccum, M. et al. 2002.
Cytokine requirements for acute and Basal homeostatic pro-
liferation of naive and memory CD8+ T cells. J. Exp. Med.
195:1515.
28 Lodolce, J., Burkett, P., Koka, R. et al. 2002. Interleukin-15 and the
regulation of lymphoid homeostasis. Mol. Immunol. 39:537.
29 Chiu, W. K., Fann, M. and Weng, N. P. 2006. Generation and
growth of CD28nullCD8+ memory T cells mediated by IL-15 and
its induced cytokines. J. Immunol. 177:7802.
30 Coico, R. 1998. Current Protocols in Immunology. John Wiley &
Sons, Inc, Hoboken, NJ, USA.
31 Lyons, A. B. 2000. Analysing cell division in vivo and in vitro using
ﬂow cytometric measurement of CFSE dye dilution. J. Immunol.
Methods 243:147.
32 Wells, A. D., Gudmundsdottir, H. and Turka, L. A. 1997. Following
the fate of individual T cells throughout activation and clonal
expansion. Signals from T cell receptor and CD28 differentially
regulate the induction and duration of a proliferative response.
J. Clin. Invest. 100:3173.
33 Badley, A. D., Parato, K., Cameron, D. W. et al. 1999. Dynamic
correlation of apoptosis and immune activation during treatment of
HIV infection. Cell Death Differ. 6:420.
34 Morrot, A., Hafalla, J. C., Cockburn, I. A., Carvalho, L. H. and
Zavala, F. 2005. IL-4 receptor expression on CD8+ T cells
is required for the development of protective memory re-
sponses against liver stages of malaria parasites. J. Exp. Med.
202:551.
35 Yokoyama, T., Tanahashi, M., Kobayashi, Y. et al. 2002. The
expression of Bcl-2 family proteins (Bcl-2, Bcl-x, Bax, Bak and
Bim) in human lymphocytes. Immunol. Lett. 81:107.
36 Sasson, S. C., Zaunders, J. J. and Kelleher, A. D. 2006. The IL-7/
IL-7 receptor axis: understanding its central role in T-cell
homeostasis and the challenges facing its utilization as a novel
therapy. Curr. Drug Targets 7:1571.
37 Colle, J. H., Moreau, J. L., Fontanet, A. et al. 2006. Regulatory
dysfunction of the interleukin-7 receptor in CD4 and CD8
lymphocytes from HIV-infected patients—effects of antiretroviral
therapy. J. Acquir. Immune Deﬁc. Syndr. 42:277.
38 Kittipatarin, C. and Khaled, A. R. 2007. Interlinking interleukin-7.
Cytokine 39:75.
39 Marrack, P. and Kappler, J. 2004. Control of T cell viability. Annu.
Rev. Immunol. 22:765.
40 Teh, S. J., Dutz, J. P., Motyka, B. and Teh, H. S. 1996. Fas (CD95)-
independent regulation of immune responses by antigen-speciﬁc
CD4-CD8+ T cells. Int. Immunol. 8:675.
41 Fluur, C., De Milito, A., Fry, T. J. et al. 2007. Potential role for IL-7 in
Fas-mediated T cell apoptosis during HIV infection. J. Immunol.
178:5340.
42 Swainson, L., Kinet, S., Mongellaz, C., Sourisseau, M., Henriques,
T. and Taylor, N. 2007. IL-7-induced proliferation of recent thymic
emigrants requires activation of the PI3K pathway. Blood
109:1034.
43 Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D.
and Ahmed, R. 2003. Selective expression of the interleukin 7
receptor identiﬁes effector CD8 T cells that give rise to long-lived
memory cells. Nat. Immunol. 4:1191.
44 Badovinac, V. P., Porter, B. B. and Harty, J. T. 2004. CD8+ T cell
contraction is controlled by early inﬂammation. Nat. Immunol.
5:809.
45 Buentke, E., Mathiot, A., Tolaini, M., Di Santo, J., Zamoyska, R.
and Seddon, B. 2006. Do CD8 effector cells need IL-7R
expression to become resting memory cells? Blood 108:1949.
46 Swainson, L., Verhoeyen, E., Cosset, F. L. and Taylor, N. 2006. IL-
7R alpha gene expression is inversely correlated with cell cycle
progression in IL-7-stimulated T lymphocytes. J. Immunol.
176:6702.
47 Park, J. H., Yu, Q., Erman, B. et al. 2004. Suppression of
IL7Ralpha transcription by IL-7 and other prosurvival cytokines:
a novel mechanism for maximizing IL-7-dependent Tcell survival.
Immunity 21:289.
48 Vranjkovic, A., Crawley, A. M., Gee, K., Kumar, A. and Angel, J. B.
2007. IL-7 decreases IL-7 receptor alpha (CD127) expression and
induces the shedding of CD127 by human CD8+ T cells. Int.
Immunol. 19:1329.
49 Colle, J. H., Moreau, J. L., Fontanet, A. et al. 2006. CD127
expression and regulation are altered in the memory CD8 Tcells of
HIV-infected patients—reversal by highly active anti-retroviral
therapy (HAART). Clin. Exp. Immunol. 143:398.
50 Young, C. D. and Angel, J. B. 2006. Optimization of culture and
storage conditions for an in vitro system to evaluate thymocyte
phenotype and function. J. Immunol. Methods 312:157.
51 Lacombe, M. H., Hardy, M. P., Rooney, J. and Labrecque, N.
2005. IL-7 receptor expression levels do not identify CD8+
memory T lymphocyte precursors following peptide immunization.
J. Immunol. 175:4400.
52 Riou, C., Yassine-Diab, B., Van grevenynghe, J. et al. 2007.
Convergence of TCR and cytokine signaling leads to FOXO3a
phosphorylation and drives the survival of CD4+ central memory
T cells. J. Exp. Med. 204:79.
Division and apoptosis of CD8
+CD127
+/ T cells 4153 van Grevenynghe, J., Procopio, F. A., He, Z. et al. 2008.
Transcription factor FOXO3a controls the persistence of memory
CD4(+) T cells during HIV infection. Nat. Med. 14:266.
54 Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H. and Cory,
S. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to
lymphocyte apoptosis. EMBO J. 14:6136.
55 Giri, J. G., Kumaki, S., Ahdieh, M. et al. 1995. Identiﬁcation and
cloning of a novel IL-15 binding protein that is structurally related
to the alpha chain of the IL-2 receptor. EMBO J. 14:3654.
56 Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. and Marrack,
P. 2000. Control of homeostasis of CD8+ memory T cells by
opposing cytokines. Science 288:675.
57 Naora, H. and Gougeon, M. L. 1999. Interleukin-15 is a potent
survival factor in the prevention of spontaneous but not CD95-
induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected
individuals. Correlation with its ability to increase BCL-2 expres-
sion. Cell Death Differ. 6:1002.
58 Harari, A., Dutoit, V., Cellerai, C., Bart, P. A., Du Pasquier, R. A.
and Pantaleo, G. 2006. Functional signatures of protective antiviral
T-cell immunity in human virus infections. Immunol. Rev. 211:236.
59 Vudattu, N. K., Magalhaes, I., Schmidt, M., Seyfert-Margolis, V. and
Maeurer, M. J. 2007. Reduced numbers of IL-7 receptor (CD127)
expressing immune cells and IL-7-signaling defects in peripheral
blood from patients with breast cancer. Int. J. Cancer 121:1512.
60 Rethi, B., Fluur, C., Atlas, A. et al. 2005. Loss of IL-7Ralpha is
associated with CD4 T-cell depletion, high interleukin-7 levels and
CD28 down-regulation in HIV infected patients. AIDS 19:2077.
61 Oehen, S. and Brduscha-Riem, K. 1999. Naive cytotoxic
T lymphocytes spontaneously acquire effector function in lym-
phocytopenic recipients: a pitfall for T cell memory studies? Eur.
J. Immunol. 29:608.
42 Division and apoptosis of CD8
+CD127
+/ T cells